In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Thomas H Marwick
Speaker
Thomas H Marwick
Thomas H Marwick Thomas H Marwick

Baker Heart and Diabetes Institute, Melbourne (Australia)

Specialities : Echocardiography , Coronary Artery Disease Chronic, Risk Factors and Prevention

THOMAS MARWICK, MBBS, PhD, MPH Tom Marwick is the Director of Baker Heart and Diabetes Institute. His education was completed at University of Melbourne, Australia; University of Louvain, Belgium and Harvard. His main contribution are in clinical research and research training, and has supervised more than 30 research higher-degree students. He was one of the initiators of stress echocardiography, and has made contributions to the prognostic evidence underlying cardiovascular imaging. His main research interests relate to detection of early cardiovascular disease and cost-effective application of cardiac imaging techniques for treatment. He has published over 650 papers, reviews, chapters and editorials, and is an Associate Editor at JACC and Deputy Editor at JACC-Cardiovascular Imaging.

33 presentations from this speaker

Artificial intelligence in cardiovascular imaging: what the clinician should know.

Event : ESC Congress 2019

  • Session : Novel technologies and artificial intelligence in cardiovascular imaging
  • Speaker : T Marwick (Melbourne,AU)

Chemotherapy and the heart: the optimal diagnostic approach to cardiotoxicity

Event : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
  • Speaker : T Marwick (Melbourne,AU)

Echo to guide therapy.

Event : EuroEcho 2019

  • Session : More awareness about diabetes and heart failure
  • Speaker : T Marwick (Melbourne,AU)

Ejection fraction is an important indicator of outcome - CON.

Event : ESC Congress 2019

  • Session : Controversies in heart failure
  • Speaker : T Marwick (Melbourne,AU)

Expert advice: cardiac imaging for risk stratification in ischemic heart disease.

Event : ESC Congress 2019

  • Session : Expert Advice - Cardiac imaging for risk stratification
  • Speaker : T Marwick (Melbourne,AU)

Journal of the American College of Cardiology imaging.

Event : EuroEcho 2019

  • Session : The fantastic 4: the 4 best papers of my journal in 2018
  • Speaker : T Marwick (Melbourne,AU)

Left ventricular hemodynamics in heart failure.

Event : EuroEcho 2019

  • Session : Non-invasive hemodynamic assessment in different contexts
  • Speaker : T Marwick (Melbourne,AU)

Machine learning applied to energy waveform ECG for prediction of subclinical myocardial dysfunction

Event : ESC Congress 2019

  • Session : Prevention - Risk assessment
  • Speaker : T Marwick (Melbourne,AU)

Preclinical diastolic dysfunction assessed by left atrial strain and association with incident heart failure

Event : ESC Congress 2019

  • Session : New approaches to diastolic function assessment
  • Speaker : T Marwick (Melbourne,AU)

Speckle tracking in coronary disease: view through the bullĀ“s eye?

Event : EuroEcho 2019

  • Session : What is speckle tracking and why do we need it?
  • Speaker : T Marwick (Melbourne,AU)

Use of LV Deformation Imaging to predict long term Heart Failure Risk in high risk patients

Event : ESC Congress 2019

  • Session : Imaging, miscellaneous
  • Speaker : T Marwick (Melbourne,AU)

Assessment of left ventricular function in aortic stenosis. Strain is all I need.

Event : EuroEcho 2018

  • Session : EuroEcho Lecture and Dr Jekyll & Mr Hyde session
  • Speaker : T Marwick (Melbourne,AU)

Assessment of left ventricular function in aortic stenosis: Ejection fraction is all I need.

Event : EuroEcho 2018

  • Session : EuroEcho Lecture and Dr Jekyll & Mr Hyde session
  • Speaker : T Marwick (Melbourne,AU)

Cardiac amyloidosis: the apical sparing.

Event : EuroEcho 2018

  • Session : Phenotyping hypertrophy using imaging
  • Speaker : T Marwick (Melbourne,AU)

Echocardiography of hypertrophic cardiomyopathies.

Event : ESC Congress 2018

  • Session : Image Interpretation with the Masters: Left ventricular hypertrophy
  • Speaker : T Marwick (Melbourne,AU)

Left ventricular geometry and function.

Event : EuroEcho 2018

  • Session : The added value of 3D echo to assess patient outcome
  • Speaker : T Marwick (Melbourne,AU)

Strain analyses to identify amyloidosis and myocarditis.

Event : ESC Congress 2018

  • Session : Easy to measure, hard to understand: a review of left ventricular strain in echocardiography
  • Speaker : T Marwick (Melbourne,AU)

The role of advanced cardiac imaging in heart failure with reduced ejection fraction.

Event : EuroEcho 2018

  • Session : Heart Failure with left ventricular systolic dysfunction: beyond ejection fraction
  • Speaker : T Marwick (Melbourne,AU)

Treatment of cardiotoxicity: does it help?

Event : EuroEcho 2018

  • Session : Cardio-oncology: the role of basic and advanced imaging
  • Speaker : T Marwick (Melbourne,AU)

Clincal evidence matters - When and how to use 2D speckle tracking today? .

Event : EuroEcho 2017

  • Session : Clinical use of 2D Speckle Tracking - Hopes and Facts
  • Speaker : T Marwick (Melbourne,AU)

Edler lecture: "Recognizing the elephant in the room. Quality control in imaging".

Event : EuroEcho 2017

  • Session : Inaugural session
  • Speaker : T Marwick (Melbourne,AU)

Hypertension and aortic stenosis - What do the guidelines say?

Event : ESC Congress 2017

  • Session : Hypertension and heart failure in valvular disease
  • Speaker : T Marwick (Melbourne,AU)

Is it time to replace the measurement of ejection fraction?

Event : Heart Failure 2017

  • Session : How imaging can guide clinical decision making in heart failure
  • Speaker : T Marwick (Melbourne,AU)

State of the Art: imaging the hypertensive heart

Event : ESC Congress 2017

  • Session : Hypertension - Heavy hearts, big problems
  • Speaker : T Marwick (Melbourne,AU)

State of the Art: stress echocardiography rediscovered

Event : ESC Congress 2017

  • Session : Stress echocardiography
  • Speaker : T Marwick (Melbourne,AU)

Strain parameters are useful in the daily practice. PRO.

Event : EuroEcho 2017

  • Session : Is advanced assessment of LV function ready for prime time?
  • Speaker : T Marwick (Melbourne,AU)

Evaluation of myocardial fibrosis. Are imaging techniques ready for prime time?

Event : ESC Congress 2016

  • Session : Cardiac fibrosis quo vadis?
  • Speaker : T Marwick (Melbourne,AU)
  • Organised by Council on Basic Cardiovascular Science (CBCS)

Aortic valve orientation and root angles are associated with aortic dilatation pattern and acute aortic event risk

Event : ESC Congress 2015

  • Session : Computed tomography use in structural heart disease
  • Speaker : T Marwick (Melbourne,AU)

Detection of cardiotoxicity: an imaging overview.

Event : ESC Congress 2015

  • Session : Management and prevention of cardiotoxicity secondary to cancer drugs
  • Speaker : T Marwick (Melbourne,AU)

Stable coronary heart disease.

Event : ESC Congress 2015

  • Session : Imaging guided management in recent ESC Guidelines
  • Speaker : T Marwick (Melbourne,AU)

The myocardial matrix as a diagnostic and therapeutic target.

Event : ESC Congress 2015

  • Session : Novel imaging targets for cardiac disease
  • Speaker : T Marwick (Melbourne,AU)

Imaging and oncology: a need for standardised protocols?

Event : ESC Congress 2013

  • Session : Why do we need cardiac imaging in cancer therapy?
  • Speaker : T Marwick (Melbourne,AU)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are